期刊文献+

基于Bayes法的C-12蛋白芯片联合检测判别函数的建立及临床意义分析 被引量:5

Establishment of multiple tumor marker discriminant function,its clinical significance for tumor diagnosis,and the differences with C-12 protein chip based on Bayes method
下载PDF
导出
摘要 目的结合C-12蛋白芯片检测结果,采用Bayes法建立多肿瘤标志物判别函数,以明确肿瘤类型,提高肿瘤诊断准确率;比较多肿瘤标志物判别函数与C-12多肿瘤标志物蛋白芯片检测系统的差异及对肿瘤诊断的临床意义。方法用C-12蛋白芯片法检测2 177例恶性肿瘤患者(肺癌836例,肝癌318例,胰腺癌84例,胃癌123例,肠癌338例,乳腺癌206例,卵巢癌47例,子宫内膜癌28例,食管癌197例)和2 111例正常及患良性疾病的非肿瘤患者的12项常见肿瘤标志物,并结合临床资料进行回顾性研究。应用Bayes法建立肿瘤判别诊断函数,比较12种肿瘤标志物和判别诊断函数对肿瘤诊断的准确率差异。结果成功建立了多肿瘤标志物的三级诊断判别函数。一级判别函数诊断的特异度为82.11%,灵敏度为71.28%,准确率为83.97%,而C-12蛋白芯片法检测12项肿瘤标志物的特异度为70.11%,灵敏度为66.10%,准确率为68.07%。二级判别函数能显著提高10种常规肿瘤诊断的灵敏度、特异度和准确率。三级诊断判别函数对确定部分肿瘤的类型有意义。结论基于Bayes法建立的C-12蛋白芯片联合检测判别函数具有较高的灵敏度、特异度和准确率,对肿瘤的诊断具有重要临床价值。 Objective To establish the diagnostic function by Bayesian method to identify the type of tumor and evaluate the accuracy rate. The difference between the diagnostic function and the C-12 multiple tumor marker protein chip system was compared to evaluate their clinical significance for tumor diagnosis. Methods A retrospective study was done on the data of 2177 patients with malignant tumors (836 with lung cancer, 318 with liver cancer, 84 with pancreatic cancer, 123 with gastric cancer, 338 with colorectal cancer, 206 with breast cancer, 47 with ovarian cancer, 28 with endometrial cancer, and 197 with esophageal cancer) and 2111 normal and benign lesions (control group), in whom 12 tumor markers were detected by protein chip technology. Furthermore, the diagnostic function was established by Bayesian method to compare the accuracy for tumor diagnosis with these 12 tumor markers. Results 1) The tertiary diagnostic function was successfully established in C-12 multiple tumor markers. 2) The specificity, sensitivity and accuracy were 70. 11%, 66. 10% and 68. 07%, respectively, by C-12 multiple tumor markers, while 82. 11%, 71.28% and 83. 97% by the first grade of diagnostic function. 3) The accuracy, sensitivity and specificity were higher than that of C-12 multiple tumor marker chip in all the 10 types of malignant tumors by the second grade of diagnostic function. 4) The third grade of diagnostic function could identify a part of the tumor types, such as breast cancer, prostate cancer, lung cancer, liver cancer, ovarian cancer, endometrial cancer and pancreatic cancer. Conclusion Diagnostic functions established by Bayesian methods have such advantages as high sensitivity, specificity and accuracy, and are of great clinical value in early diagnosis of cancers.
出处 《解放军医学杂志》 CAS CSCD 北大核心 2009年第1期34-37,40,共5页 Medical Journal of Chinese People's Liberation Army
关键词 肿瘤标记 生物学 肿瘤 贝叶斯定理 模型 统计学 蛋白质阵列分析 tumor markers, biological tumors Bayes theorem models, statistical protein array analysis
  • 相关文献

参考文献12

  • 1Weinberger SR, Dalmasso EA, Fung ET. Current achievements using protein chip array technology. Curt Opin Chem Biol, 2002, 6 (1):86
  • 2Sun Z, Fu X, Zhang L, et al. A protein chip system for parallel analysis of multi-tumor markers and its application in cancer detection. Anticancer Res, 2004, 24 (2C) : 1159
  • 3Montomoli C, Nichelatti M. Bayesian statistics in medicine - part Ⅱ: main applications and inference G Ital Nefrol, 2008, 25(4) :422
  • 4杨雪琴,王东,李增鹏,王阁,杨镇洲,杨志祥,杨玉磬,蒋耀光.多肿瘤标志物蛋白芯片监测肺癌复发进展及转移的临床意义[J].中国肺癌杂志,2007,10(4):296-300. 被引量:5
  • 5仲召阳,王东,李增鹏,李梦侠,戴楠,曹晓静,王佳,关伟.多肿瘤标志物蛋白质芯片检测系统对结直肠癌诊断的临床意义[J].重庆医学,2007,36(23):2406-2408. 被引量:16
  • 6Sreekumar A, Chinnaiyan AM. Using protein rnicroarrays to study cancer. Biotechniques, 2002, (Suppl) :46
  • 7董学君,陈建军,郑专,王贵珍,单水阳,王伟,傅燕萍.多肿瘤指标联合诊断肝癌的函数建立和应用[J].检验医学,2006,21(3):255-258. 被引量:5
  • 8Mrochem J, Sodowski K, Deja R, et al. Evaluation of selected serum protein markers as early detectors of ovarian cancer. Ginekol Pol, 2008, 79(4) :271
  • 9Visintin I, Feng ZD, I.ongton G, et al. Diagnostic markers for early detection of ovarian cancer. Clin Cancer Res, 2008, 14(4) :1065
  • 10Verzilli C, Shah T, Casas JP, et al. Bayesian meta-analysis of genetic association studies with different sets of markers. Am J Hum Genet, 2008, 82(4) :859

二级参考文献21

  • 1罗速,张逢春,刘成柏,项小丰.肿瘤标志物联合检测在原发性肝细胞癌早期诊断中的应用[J].吉林大学学报(理学版),2004,42(4):625-627. 被引量:5
  • 2[2]von Eggeling F,Davies H,Lomas L,et al.Tissue-specific microdissection coupled with ProteinChip array technologies:applications in cancer research.Biotechniques,2000,29(5):1066-1070.
  • 3[3]Weinberger SR,Dalmasso EA,Fung ET.Current achievements using ProteinChip Array technology.Curr Opin Chem Biol,2002,6(1):86-91.
  • 4[5]Hatzakis KD,Froudarakis ME,Bouros D,et al.Prognostic value of serum tumor markers in patients with lung cancer.Respiration,2002,69(1):25-29.
  • 5[7]Ando S,Kimura H,Iwai N,et al.Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer.Anticancer Res,2001,21(4B):3085-3092.
  • 6[8]Salgia R,Harpole D,Herndon JE,et al.Role of serum tumor markers CA 125 and CEA in non-small cell lung cancer.Anticancer Res,2001,21(2B):1241-1246.
  • 7[9]Niklinski J,Furman M.Clinical tumour markers in lung cancer.Eur J Cancer Prev,1995,4(2):129-138.
  • 8[10]Milman N,Pedersen LM.The serum ferritin concentration is a significant prognostic indicator of survival in primary lung cancer.Oncol Rep,2002,9(1):193-198.
  • 9[11]Fracchia A,Ubbiali A,El Bitar O,et al.A comparative study on ferritin concentration in serum and bilateral bronchoalveolar lavage fluid of patients with peripheral lung cancer versus control subjects.Oncology,1999,56(3):181-188.
  • 10[12]Okunaka T,Kato H,Konaka C,et al.Primary lung cancer producing alpha-fetoprotein.Ann Thorac Surg,1992,53(1):151-152.

共引文献21

同被引文献50

引证文献5

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部